Summit Therapeutics Inc. (SMMT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Summit Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -12.11x | -72.09x | -3.35x | -12.53x | -3.79x | -8.46x |
| P/B Ratio | 26.74x | 41.02x | 26.30x | 7.91x | 4.02x | 5.58x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 1400.30x | 185.48x | 518.21x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | -10225.4% | -4764.3% | -6185.2% |
| Net Margin | 0.0% | 0.0% | 0.0% | -11174.8% | -4897.8% | -6127.6% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | -8845.1% | -4689.8% | -5904.9% |
| Liquidity | ||||||
| Current Ratio | 9.87x | 10.15x | 9.30x | 16.93x | 3.80x | 4.41x |
| Quick Ratio | 9.87x | 10.15x | 9.30x | 16.93x | 3.80x | 4.41x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.02x | 1.37x | 4.10x | 0.03x | 0.01x |
YoY = year-over-year change. Source: FMP..